There are no products in your shopping cart.
Hormone Balance
An experimental menopause treatment that drugmaker Wyeth is developing reduced hot flashes, trouble sleeping and other symptoms and did not increase breast tenderness, a problem that bothers many women taking menopause drugs, according to data from two studies released Thursday.
Unlike men, there are no approved drugs to take. If you go strictly by the rules, the best medical science has to offer is counseling, or a device that applies suction to your clitoris, or physical therapy for your vagina. While not to diminish these choices, where's that convenient, little blue pill for women?
That's what Joanne wanted to know. This isn't her real name, but she's a 26-year-old nurse at the Cleveland Clinic who felt no sex drive -- nothing, nada, zilch -- for eight years. She wasn't happy, and neither was her boyfriend.
Lisle Nolan started noticing the symptoms four months ago: headaches, mood swings and a menstrual cycle that was out of whack.
"It's the exact same symptoms as my period, but I get them every two weeks," said Nolan, 46, a communications executive from Atlanta, Georgia.
Nolan went online to research what was going on, but it was her gynecologist who confirmed the diagnosis: perimenopause.
As reported in the American Journal of Cardiology, women whose ratio of LDL ("bad") cholesterol to HDL ("good") cholesterol came to less than 2.5 had no increased risk of a heart attack or angina while using estrogen alone or with progesterone. By contrast, a ratio of 2.5 or higher was associated with a 73 percent higher likelihood of heart-related illness.
A woman's race and ethnicity appear to be important predictors of the age at which she will enter menopause, study findings hint.
Compared with non-Latina White women, natural menopause appears to occur at an earlier age among Latina women and a later age among Japanese-American women, Dr. Katherine DeLellis Henderson and colleagues found.
Age at natural menopause among African American and Native Hawaiian women appears similar to that of non-Latina White women.
A potent bone-building drug may cut the risk of relapse in premenopausal women with early breast cancer, a study shows.
In a study of more than 1,800 patients, women who got two injections a year of the bone drug Zometa were about one-third less likely to suffer a recurrence than those who did not.
Results from a decades-long study may enable women to drink coffee or tea without worry that doing so will increase their risk for breast cancer, study findings suggest.

YBM Life!







"The best of all healing worlds -- modern Western medicine blended with centuries-old Oriental wisdom."